Juliette Paireau

4.3k total citations · 3 hit papers
46 papers, 2.1k citations indexed

About

Juliette Paireau is a scholar working on Infectious Diseases, Modeling and Simulation and Epidemiology. According to data from OpenAlex, Juliette Paireau has authored 46 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 22 papers in Modeling and Simulation and 21 papers in Epidemiology. Recurrent topics in Juliette Paireau's work include COVID-19 epidemiological studies (22 papers), SARS-CoV-2 and COVID-19 Research (12 papers) and Influenza Virus Research Studies (8 papers). Juliette Paireau is often cited by papers focused on COVID-19 epidemiological studies (22 papers), SARS-CoV-2 and COVID-19 Research (12 papers) and Influenza Virus Research Studies (8 papers). Juliette Paireau collaborates with scholars based in France, United Kingdom and United States. Juliette Paireau's co-authors include Simon Cauchemez, Arnaud Fontanet, Henrik Salje, Megan O’Driscoll, Derek A. T. Cummings, Gabriel Ribeiro dos Santos, Lin Wang, Andrew S. Azman, D Lévy-Brühl and Nathanaël Hozé and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Juliette Paireau

43 papers receiving 2.1k citations

Hit Papers

Age-specific mortality and immunity patterns of SARS-CoV-2 2020 2026 2022 2024 2020 2020 2024 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Age-specific mortality and immunity patterns of SARS-CoV-2
    2020 712 citations Megan O’Driscoll, Derek A. T. Cummings et al. profile →
  2. Estimating the burden of SARS-CoV-2 in France
    2020 636 citations Henrik Salje, Cécile Tran Kiem et al. Science profile →
  3. Nirsevimab Effectiveness Against Cases of Respiratory Syncytial Virus Bronchiolitis Hospitalised in Paediatric Intensive Care Units in France, September 2023–January 2024
    2024 44 citations Juliette Paireau, C. Durand et al. Influenza and Other Respiratory Viruses profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juliette Paireau France 17 1.1k 853 485 242 230 46 2.1k
Christine Tedijanto United States 7 766 0.7× 811 1.0× 293 0.6× 316 1.3× 142 0.6× 13 1.9k
Ethan Romero-Severson United States 18 964 0.9× 624 0.7× 376 0.8× 219 0.9× 198 0.9× 48 1.9k
Mike Yat Wah Kwan Hong Kong 24 1.6k 1.4× 686 0.8× 809 1.7× 255 1.1× 263 1.1× 72 2.8k
Flavia Riccardo Italy 26 995 0.9× 403 0.5× 361 0.7× 113 0.5× 372 1.6× 99 1.9k
Melissa A. Rolfes United States 22 1.3k 1.2× 399 0.5× 1.5k 3.0× 110 0.5× 220 1.0× 81 2.7k
Müge Çevik United Kingdom 26 2.2k 2.0× 819 1.0× 533 1.1× 127 0.5× 264 1.1× 65 3.5k
Gavin Dabrera United Kingdom 17 2.2k 2.0× 741 0.9× 576 1.2× 118 0.5× 857 3.7× 61 3.2k
Massimo Fabiani Italy 30 1.1k 1.0× 255 0.3× 577 1.2× 130 0.5× 493 2.1× 107 2.5k
Sara E. Oliver United States 20 1.6k 1.5× 384 0.5× 677 1.4× 135 0.6× 1.0k 4.5× 54 2.9k
Charles Beck United Kingdom 25 901 0.8× 216 0.3× 610 1.3× 151 0.6× 125 0.5× 65 2.7k

Countries citing papers authored by Juliette Paireau

Since Specialization
Citations

This map shows the geographic impact of Juliette Paireau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juliette Paireau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juliette Paireau more than expected).

Fields of papers citing papers by Juliette Paireau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juliette Paireau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juliette Paireau. The network helps show where Juliette Paireau may publish in the future.

Co-authorship network of co-authors of Juliette Paireau

This figure shows the co-authorship network connecting the top 25 collaborators of Juliette Paireau. A scholar is included among the top collaborators of Juliette Paireau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juliette Paireau. Juliette Paireau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Casalegno, Jean‐Sébastien, Benoît Visseaux, Vincent Enouf, et al.. (2025). Community and Hospital‐Based Laboratory Surveillance for Influenza, Respiratory Syncytial Virus, and SARS‐CoV‐2 During the 2023–2024 Season, Lyon, France. Journal of Medical Virology. 97(9). e70549–e70549.
3.
Paireau, Juliette, C. Durand, S. Raimbault, et al.. (2024). Nirsevimab Effectiveness Against Cases of Respiratory Syncytial Virus Bronchiolitis Hospitalised in Paediatric Intensive Care Units in France, September 2023–January 2024. Influenza and Other Respiratory Viruses. 18(6). e13311–e13311. 44 indexed citations breakdown →
4.
Enouf, Vincent, Juliette Paireau, Marie‐Anne Rameix‐Welti, et al.. (2024). Effect of nirsevimab on hospitalisations for respiratory syncytial virus bronchiolitis in France, 2023–24: a modelling study. The Lancet Child & Adolescent Health. 8(10). 721–729. 11 indexed citations
5.
Kiem, Cécile Tran, Valérie Olié, Juliette Paireau, et al.. (2023). Modelling the end of a Zero-COVID strategy using nirmatrelvir/ritonavir, vaccination and NPIs in Wallis and FutunaResearch in context. SHILAP Revista de lepidopterología. 4 indexed citations
6.
Andronico, Alessio, Henrik Salje, Muriel Vincent, et al.. (2023). Comparing the Performance of Three Models Incorporating Weather Data to Forecast Dengue Epidemics in Reunion Island, 2018–2019. The Journal of Infectious Diseases. 229(1). 10–18. 3 indexed citations
7.
Paireau, Juliette, Marie‐Laure Charpignon, Sophie Larrieu, et al.. (2023). Impact of non-pharmaceutical interventions, weather, vaccination, and variants on COVID-19 transmission across departments in France. BMC Infectious Diseases. 23(1). 190–190. 11 indexed citations
8.
Tamandjou, Cynthia, Cécile Sommen, Fanny Chéreau, et al.. (2023). Impact of vaccination against severe COVID-19 in the French population aged 50 years and above: a retrospective population-based study. BMC Medicine. 21(1). 426–426. 2 indexed citations
9.
Antona, Denise, et al.. (2023). Two-dose measles vaccine effectiveness remains high over time: A French observational study, 2017–2019. Vaccine. 41(39). 5797–5804. 13 indexed citations
10.
Lévy, Corinne, Jérémie F. Cohen, Stéphane Béchet, et al.. (2022). Association between the COVID-19 pandemic and pertussis derived from multiple nationwide data sources, France, 2013 to 2020. Eurosurveillance. 27(25). 31 indexed citations
11.
Metcalf, C. Jessica E., Juliette Paireau, Megan O’Driscoll, et al.. (2022). Comparing the age and sex trajectories of SARS-CoV-2 morbidity and mortality with other respiratory pathogens. Royal Society Open Science. 9(6). 211498–211498. 12 indexed citations
12.
Paireau, Juliette, Alessio Andronico, Nathanaël Hozé, et al.. (2022). An ensemble model based on early predictors to forecast COVID-19 health care demand in France. Proceedings of the National Academy of Sciences. 119(18). e2103302119–e2103302119. 25 indexed citations
13.
Durand, C., Y. Hassani, Juliette Paireau, et al.. (2022). Reconstructing Mayotte 2018–19 Rift Valley Fever outbreak in humans by combining serological and surveillance data. SHILAP Revista de lepidopterología. 2(1). 163–163. 5 indexed citations
14.
Galmiche, Simon, Tiffany Charmet, Laura Schaeffer, et al.. (2021). Exposures associated with SARS-CoV-2 infection in France: A nationwide online case-control study. The Lancet Regional Health - Europe. 7. 100148–100148. 56 indexed citations
15.
Andronico, Alessio, Cécile Tran Kiem, Juliette Paireau, et al.. (2021). Evaluating the impact of curfews and other measures on SARS-CoV-2 transmission in French Guiana. Nature Communications. 12(1). 1634–1634. 28 indexed citations
16.
Paireau, Juliette, Sophie Guillot, Fatima Aït El Belghiti, et al.. (2021). Effect of change in vaccine schedule on pertussis epidemiology in France: a modelling and serological study. The Lancet Infectious Diseases. 22(2). 265–273. 14 indexed citations
17.
Lefrancq, Noémie, Juliette Paireau, Nathanaël Hozé, et al.. (2021). Evolution of outcomes for patients hospitalised during the first 9 months of the SARS-CoV-2 pandemic in France: A retrospective national surveillance data analysis. The Lancet Regional Health - Europe. 5. 100087–100087. 28 indexed citations
18.
Salje, Henrik, Cécile Tran Kiem, Noémie Lefrancq, et al.. (2020). Estimating the burden of SARS-CoV-2 in France. Science. 369(6500). 208–211. 636 indexed citations breakdown →
19.
20.
Flamand, Claude, Sarah Bailly, Camille Fritzell, et al.. (2019). Impact of Zika Virus Emergence in French Guiana: A Large General Population Seroprevalence Survey. The Journal of Infectious Diseases. 220(12). 1915–1925. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine Tedijanto Breakdown of academic impact, for papers by Ethan Romero-Severson Breakdown of academic impact, for papers by Mike Yat Wah Kwan Breakdown of academic impact, for papers by Flavia Riccardo Breakdown of academic impact, for papers by Melissa A. Rolfes Breakdown of academic impact, for papers by Müge Çevik Breakdown of academic impact, for papers by Gavin Dabrera Breakdown of academic impact, for papers by Massimo Fabiani Breakdown of academic impact, for papers by Sara E. Oliver Breakdown of academic impact, for papers by Charles Beck
Rankless by CCL
2026